CareX
Illkirch
About CareX
CareX SA is a biopharmaceutical company that develops novel treatments for metabolic and immune system disorders which includes diabetes and obesity. The company focuses on metabolic syndrome, a cluster of inter-related disorders of the body’s metabolism, including high blood pressure, high insulin levels, excess body weight, and abnormal cholesterol levels, that exposes individuals to the development of type 2 diabetes, heart diseases, and strokes. CareX SA is a France-based company that was founded in 2001 and the company was acquired by 7TM Pharma on May 24, 2006.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Total funding: $32.0M
- Funding stage: M&A
- Last round: Series B (Mar 2004)
- Website: carex.fr
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Life Science
Canonical: https://fsome.com/organization/carex-3631874 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.